Cagrilintide
PopularLong-acting amylin analog
Research use only Third-party tested
Research context
Human obesity trials and combination studies exist, but cagrilintide availability and indications remain investigational or product-specific by jurisdiction.
- Interest in appetite control and weight-management outcomes.
- Frequently discussed as CagriSema when paired with semaglutide.
- Online claims often outpace approved-use status.
Evidence snapshot
See full evidence tabLast updated: June 2025
Mechanism of action
Long-acting amylin analog studied alone and with semaglutide.
Learn more about mechanismQuick facts
- Aliases
- Cagri
- Molecular weight
- TBD
- Sequence length
- TBD
- Product type
- Synthetic
- CAS / Registry
- TBD
- Appearance
- White lyophilized powder
- Solubility
- Water
Safety notes
For research use only. Not for human or veterinary use.
- Common research observations: nausea, reduced appetite, GI discomfort
- Monitor hydration and nutrient intake in long-term studies
- Consult current literature for full safety profile and contraindications
Popular research protocols
View all protocolsResearch use onlyAll peptides are intended for laboratory research purposes only. Not for human or veterinary use.